healthcare News
Eli Lilly falls as Wave weight-loss drug misses analyst expectations
Orforglipron's 12.4% weight loss falls short of Wall Street targets, raising questions about oral GLP-1 market potential
MeiraGTx soars on FDA breakthrough therapy, revenue surge
Gene therapy developer reports $81.4M revenue from strategic Lilly and Hologen partnerships, extends cash runway to 2027
Upstream Bio surges 12% on Phase 3 asthma strategy
Strong cash position of $341.5M supports development through 2027 as company targets $40B asthma market with TSLP inhibitor
Acumen posts $121.3M loss, cash burn accelerates before key Alzheimer's trial
Clinical-stage biotech reports $115.5M operating cash burn as it awaits late 2026 ALTITUDE-AD Phase 2 data
Dyadic shares tumble on deepening FY2025 losses
Biotechnology platform posts massive EPS miss as net losses widen to $7.36M, cash position deteriorates
SeaStar Medical plunges on 433% EPS miss despite 9x revenue surge
Biotech reports $0.80 loss per share versus $0.15 estimate, though customer base expands to 16 hospitals
Serina Therapeutics shares slide on wider loss, cash burn concerns
Clinical-stage biotech reports $19.4M net loss with R&D spending surging 76% as SER-252 trial advances
Nkarta misses Q4 estimates as cash runway extends to 2029
Biotech posts wider quarterly loss but advances autoimmune trials amid oversold conditions